Tectonic Therapeutic, Inc.
NASDAQ: TECX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Alise S. Reicin
- Employees
- 51
- Headquarters
- Watertown, United States
- IPO year
- 2018
- Market cap
- $579.7M
- Website
- https://tectonictx.com
Loading TECX…
Loading profile data…Frequently asked questions about TECX
What does Tectonic Therapeutic, Inc. (TECX) do?
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the disco...
Where does TECX trade?
Tectonic Therapeutic, Inc. (TECX) trades on the NASDAQ Global Market.
What sector is TECX in?
Tectonic Therapeutic, Inc. (TECX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Tectonic Therapeutic, Inc.?
Alise S. Reicin is the chief executive officer of Tectonic Therapeutic, Inc. (TECX).
Where is Tectonic Therapeutic, Inc. headquartered?
Tectonic Therapeutic, Inc. is headquartered in United States.
Does TECX pay a dividend?
Tectonic Therapeutic, Inc. (TECX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TECX go public?
Tectonic Therapeutic, Inc. (TECX) completed its initial public offering in 2018.